Black Rock Inc. Biocryst Pharmaceuticals Inc Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 18,440,729 shares of BCRX stock, worth $114 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,440,729
Previous 18,681,370
1.29%
Holding current value
$114 Million
Previous $112 Million
16.28%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BCRX
# of Institutions
258Shares Held
182MCall Options Held
839KPut Options Held
816K-
Vanguard Group Inc Valley Forge, PA17.7MShares$109 Million0.0% of portfolio
-
State Street Corp Boston, MA17.5MShares$108 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY13.1MShares$80.6 Million0.8% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$62.6 Million0.65% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.53MShares$40.3 Million3.48% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.15B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...